Abbott exits MNC lobby group, may join Indian Pharmaceuticals Alliance

Abbott India, among the oldest multinational drug makers, has quit the Organisation of Pharmaceuticals Producers of India, a lobby group of foreign pharma companies.

US-headquartered Abbott is the second largest drug maker in the domestic market and sells branded generics, while OPPI members primarily represent innovative pharma industry.

Abbott may now join Indian Pharmaceuticals Alliance which represents domestic generic drug makers. There is, however, no confirmation on its next step.

An Abbott spokesperson confirmed that the company was withdrawing from OPPI, but refused to comment the company's decision to join IPA. DG Shah, the Secretary-General of IPA, was not available for